Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Annu Rev Mater Res. 2015 Mar 23;45:277–310. doi: 10.1146/annurev-matsci-070214-020815

Figure 8.

Figure 8

(a) Schematic representation of citrate-based multifunctional targeting nanoparticles (MTNs) loaded with growth factors and functionalized with glycoprotein Ib (GPIb) and anti-CD34 antibodies. (b) The MTNs can be targeted to the injured endothelium and serve as a substrate to capture endothelial progenitor cells through (c) platelet mimicking. Adapted with permission from figure 1 of Reference 79.